Seralutinib🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for gossamerbio.com. This domain is officially recognized as Home - Gossamer Bio. According to their official web presence, their primary focus is: "Science Seralutinib Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).".
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 94Outbound Links: 2
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$15,642
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- gossamerbio.comTaken
- gossamerbio.netTaken
- gossamerbio.orgTaken
- gossamerbio.ioAvailable
- gossamerbio.coAvailable
- gossamerbio.aiAvailable
Official Contact & Profiles
Socials:linkedin.comx.com
Content Snippets from gossamerbio.com
"Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of its investigational drug product, seralutinib, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with these rare diseases."
"Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of its investigational drug product, seralutinib, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with these rare diseases."
"Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)."
"The PROSERA Study is a phase 3 clinical research study of seralutinib in adults with pulmonary arterial hypertension (PAH). Gossamer Bio has an unwavering and real commitment to the patient community. Our team aims to improve lives of patients through meaningful advances in the development of new therapies and an unwavering commitment to supporting patient communities across the globe."
Key Topics & Focus Areas for gossamerbio.com:
Science
Patients
Careers & Culture
By comparing gossamerbio.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to gossamerbio.com.
Frequently Asked Questions
Is gossamerbio.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of gossamerbio.com?
As of August 19, 2026, gossamerbio.com holds an estimated domain authority score of 79/100 based on our VisitRank tracking algorithms.
What are the top alternatives to gossamerbio.com?
You can find the best alternatives and similar sites to gossamerbio.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for gossamerbio.com:
gsosamerbio.comgosamerbio.comgoossamerbio.comgossamerbio.comgossemerbio.comgossamarbio.comgossamerboo.comgissamerbio.comgkssamerbio.com